APNEAMED - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 87793700
Serial Number
87793700
Word Mark
APNEAMED
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2019-02-15
Filing Date
2018-02-12
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form Typeset
Law Office Assigned Location Code
N30
Employee Name
MAZZELLA, BRANDY BARRE
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of literal elements ApneaMed in stylized shaded letters.
Goods and Services
medical testing for diagnostic or treatment purposes, namely, sleep disorder testing; medical treatment of sleep disorders
Pseudo Mark
APNEA MED
Classification Information
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-02-20
Primary Code
044
First Use Anywhere Date
2016-09-08
First Use In Commerce Date
2016-09-08
Correspondences
Name
WILLIAM SPRIGGS
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-02-20NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-05-29ASSIGNED TO EXAMINER
2018-05-31NON-FINAL ACTION WRITTEN
2018-05-31NON-FINAL ACTION E-MAILED
2018-05-31NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-06-04TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-06-04CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-06-05TEAS/EMAIL CORRESPONDENCE ENTERED
2018-06-29FINAL REFUSAL WRITTEN
2018-06-29FINAL REFUSAL E-MAILED
2018-06-29NOTIFICATION OF FINAL REFUSAL EMAILED
2019-02-15ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2019-02-15ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND